Announced today by GSK: VHIO joins five other international research centers of excellence as member of the Oncology Clinical and Translational Consortium (OCTC)

VHIO leads research proposing cerebrospinal fluid (CSF) as liquid biopsy for the early diagnosis, prognosis, therapeutic management and tracking of…

Published in Nature journal today, a multi-center study led by CIC bioGUNE´s Arkaitz Carracedo, Ikerbasque Research Professor, Associate Professor at the…

Aimed at exploring all aspects of the translational research continuum, from early detection through treatment to survivorship, this special 5-day…

A special study visit was jointly organized by the Centre of Genomic Regulation (CRG) and the European Molecular Biology Laboratory (EMBL) as partners of the EU CommHERE Communicating European Health Research Network, in collaboration with the European Union of Science Journalists’ Associations (EUSJA)
 

Recently published as an invited article in Cellular Oncology, Paolo Nuciforo, Principal Investigator of the Vall d’Hebron Institute of Oncology…

EACR 22 – from Basic Research to Personalised Cancer Treatment, 7 – 10 July 2012, Barcelona, Spain, is pleased to announce the following Pre-Congress Sympoium:

The Seve Ballesteros Foundation Special Conference on Brain Cancer, Saturday 7 July, 08:30 – 12:30h.

On 12 July 2012, internationally renowned experts in renal carcinoma, Dr. Brian Rini and Dr. Jorge García from the Cleveland…

WIN will address the most critical question facing clinical cancer research: Why the improvement of survival still remains limited for…

Initially launched back in 2011 by the EurocanPlatform, the annual Summer School in Translational Cancer Research is organized under the…

• The team will be coordinating a study that aims to investigate whether the BKM120 drug can be regarded as…

Comprised of AICR (now rebranded as Worldwide Cancer Research) donors, supporters, staff and AICR grant holders, some 15 individuals, including VHIO´s…

During the recently celebrated 24th Biennial Congress of the European Association for Cancer Research (EACR), 09 – 12 July, Manchester…

Results from an international phase III study of patients with advanced colorectal cancer, a disease which is especially difficult to…

Aflibercept vs placebo and FOLFIRI for MCRC

• The phase II study, published in The New England Journal of Medicine, shows that the most common mutation of…